Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study.

RATIONALE Obstructive sleep apnea (OSA) is an independent risk factor for stroke, but little is known about the role of continuous positive airway pressure (CPAP) on mortality in patients with stroke. OBJECTIVES To analyze the independent impact of long-term CPAP treatment on mortality in patients with ischemic stroke. METHODS Prospective observational study in 166 patients with ischemic stroke. Sleep study was performed in all of them and CPAP treatment was offered in the case of moderate to severe cases. Patients were followed-up for 5 years to analyze the risk of mortality. MEASUREMENTS AND MAIN RESULTS Of 223 patients consecutively admitted for stroke, a sleep study was performed on 166 of them (2 mo after the acute event). Thirty-one had an apnea-hypopnea index (AHI) of less than 10; 39 had an AHI between 10 and 19, and 96 had an AHI of 20 or greater. CPAP treatment was offered when AHI was 20 or greater. Patients were followed up in our outpatient clinic at 1, 3, and 6 months, and for every 6 months thereafter for 5 years (prospective observational study). Mortality data were recorded from our computer database and official death certificates. The mean age of subjects was 73.3 +/- 11 years (59% males), and the mean AHI was 26 (for all patients with a predominance of obstructive events). Patients with an AHI of 20 or greater who did not tolerate CPAP (n = 68) showed an increase adjusted risk of mortality (hazards ratio [HR], 2.69; 95% confidence interval [CI], 1.32-5.61) compared with patients with an AHI of less than 20 (n = 70), and an increased adjusted risk of mortality (HR, 1.58; 95% CI, 1.01-2.49; P = 0.04) compared with patients with moderate to severe OSA who tolerated CPAP (n = 28). There were no differences in mortality among patients without OSA, patients with mild disease, and patients who tolerated CPAP. CONCLUSIONS Our results suggest that long-term CPAP treatment in moderate to severe OSA and ischemic stroke is associated with a reduction in excess risk of mortality.

[1]  J. Stradling,et al.  Cost-effectiveness of using continuous positive airway pressure in the treatment of severe obstructive sleep apnoea/hypopnoea syndrome in the UK , 2008, Thorax.

[2]  Y. Gustafson,et al.  Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. , 2008, Archives of internal medicine.

[3]  Jan van Gijn,et al.  Acute Ischemic Stroke , 2007 .

[4]  K. Reynolds,et al.  Effect of Nocturnal Nasal Continuous Positive Airway Pressure on Blood Pressure in Obstructive Sleep Apnea , 2007, Hypertension.

[5]  Adnan I. Qureshi,et al.  Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .

[6]  A. Dupont,et al.  The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. , 2007, Archives of internal medicine.

[7]  M. Poulin,et al.  Effects of continuous positive airway pressure on cerebral vascular response to hypoxia in patients with obstructive sleep apnea. , 2007, American journal of respiratory and critical care medicine.

[8]  J. Fleetham,et al.  Impact of Continuous Positive Airway Pressure Therapy on Blood Pressure in Patients with Obstructive Sleep Apnea Hypopnea: A Meta-analysis of Randomized Controlled Trials , 2007, Lung.

[9]  Vincent M. Vacca,et al.  Acute ischemic stroke. , 2006, Nursing.

[10]  Milena Milanova,et al.  Sleep-Disordered Breathing and Acute Ischemic Stroke: Diagnosis, Risk Factors, Treatment, Evolution, and Long-Term Clinical Outcome , 2006, Stroke.

[11]  M. Martínez-García,et al.  Improvement in nocturnal disordered breathing after first-ever ischemic stroke: role of dysphagia. , 2006, Chest.

[12]  V. Chair,et al.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Circulation.

[13]  B. Phillips.  Alternative Methods of Titrating Continuous Positive Airway Pressure: A Large Multicenter Study , 2006 .

[14]  M. Martínez-García,et al.  Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. , 2005, Chest.

[15]  Jose M Marin,et al.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study , 2005, The Lancet.

[16]  P. Lavie,et al.  All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age , 2005, European Respiratory Journal.

[17]  W. Seeger,et al.  Changes in extracranial arteries in obstructive sleep apnoea , 2005, European Respiratory Journal.

[18]  J. Montserrat,et al.  Alternative methods of titrating continuous positive airway pressure: a large multicenter study. , 2004, American journal of respiratory and critical care medicine.

[19]  J. Montserrat,et al.  Sleep-related breathing disorders: impact on mortality of cerebrovascular disease , 2004, European Respiratory Journal.

[20]  P. Wanklyn,et al.  Effect of upper airway obstruction in acute stroke on functional outcome at 6 months , 2004, Thorax.

[21]  B. Gersh,et al.  Obstructive sleep apnea: implications for cardiac and vascular disease. , 2003, JAMA.

[22]  K. Lees,et al.  The prognostic value of the components of the Glasgow Coma Scale following acute stroke. , 2003, QJM : monthly journal of the Association of Physicians.

[23]  Y. Gustafson,et al.  Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. , 2001, The European respiratory journal.

[24]  A. Thilmann,et al.  Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke. , 2001, The European respiratory journal.

[25]  C W Whitney,et al.  Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. , 2001, American journal of respiratory and critical care medicine.

[26]  M. Mishima,et al.  Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. , 2000, The American journal of medicine.

[27]  C. Anderson,et al.  Five-Year Survival After First-Ever Stroke and Related Prognostic Factors in the Perth Community Stroke Study , 2000, Stroke.

[28]  J. Montserrat,et al.  Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. , 2000, American journal of respiratory and critical care medicine.

[29]  J. M. Arriero,et al.  Validación de la versión española del test de somnolencia Epworth en pacientes con síndrome de apnea de sueño , 1999 .

[30]  M. Gugger.  Comparison of ResMed AutoSet (version 3.03) with polysomnography in the diagnosis of the sleep apnoea/hypopnoea syndrome. , 1997, The European respiratory journal.

[31]  K. Chin,et al.  Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. , 1996, American journal of respiratory and critical care medicine.

[32]  V. Somers,et al.  Investigating the relationship between stroke and obstructive sleep apnea. , 1996, Stroke.

[33]  D. Good,et al.  Sleep-disordered breathing and poor functional outcome after stroke. , 1996, Stroke.

[34]  T. Young,et al.  The occurrence of sleep-disordered breathing among middle-aged adults. , 1993, The New England journal of medicine.

[35]  D. Kripke,et al.  Sleep-disordered breathing in community-dwelling elderly. , 1991, Sleep.

[36]  F. Mahoney,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.

[37]  Mahoney Fi,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 1965 .